Protolytic equilibria of rupatadine in micellar solutions of differently charged surfactants
Апстракт
Rupatadine is selective second-generation H1 antagonist, used in seasonal allergic rhinitis
and chronic urticaria, and reported to be an antagonist to platelet-activating factor.
Rupatadine contains three ionizable basic centers, two aromatic and one cyclic aliphatic
amine. The pharmaceutical dosage forms for oral administration contain rupatadine
fumarate as an active substance. A complex system of protolytic equilibria establishes in
the solution of rupatadine fumarate which includes three basic centers of rupatadine and
two acidic groups of fumaric acid. The data on the physicochemical properties of drugs
determined in aqueous solution is not sufficient for the prediction of solubility and
bioavailability in physiological conditions that are significantly more complex. For a better
understanding of pharmacological behavior of ionizable drugs their physicochemical
properties should be investigated under conditions more similar to physiological. As the
biomembrane mimetic s...ystems micellar solutions of surfactants can be used. The aim of
this study was to investigate the effect of micellar solutions of differently charged
surfactants sodium dodecyl sulfate (SDS), cetyltrimethylammonium bromide (CTAB) and
4-octylphenol polyethoxylate (TX-100), as biomembrane mimetic systems, on protolytic
equilibria of rupatadine.
The solutions (5×10-4 M) with and without of the 0.01 M surfactants were titrated with
standard NaOH solution (0.0983 M) at a constant ionic strength (0.1 M NaCl) and
temperature 25°C. Experimental data obtained by potentiometric titration were analyzed
in the program Hyperquad.
The pKa values of rupatadine (pKa1 = 3.45, pKa2 = 4.72, pKa3 = 6.75) were determined and
the ionization was defined in aqueous media. The shift in protolytic equilibria was
observed based on the pKa values of rupatadine determined in the presence of
surfactants, anionic SDS (ΔpKa up to +1.44); cationic CTAB (ΔpKa up to -1.99) and nonionic
TX-100 (ΔpKa up to -0.69). Different types of interactions between rupatadine and micelles
were assumed.
Rupatadine ionizable groups participate in electrostatic interactions with the ionic SDS and
CTAB micelles and are involved in the interactions with a hydrophilic layer of nonionic
TX-100 micelles. Observed shift in protolytic equilibria at biopharmaceutically significante
pH values can be considered in the presence of biomolecules with various charge and
polarity in physiological conditions.
Кључне речи:
Rupatadine / H1 antagonist / Physicochemical properties / Biomembrane mimetic systems / MicellesИзвор:
6th IAPC Meeting Sixth World Conference on Physico-Chemical Methods in Drug Discovery & Third World Conference on ADMET and DMPK (Book of Abstracts), 2017, 43-43Издавач:
- International Association of Physical Chemists
Финансирање / пројекти:
- Синтеза, квантитативни однос између структуре и дејства, физичко-хемијска карактеризација и анализа фармаколошки активних супстанци (RS-MESTD-Basic Research (BR or ON)-172033)
Напомена:
- 6th IAPC Meeting Sixth World Conference on Physico-Chemical Methods in Drug Discovery & Third World Conference on ADMET and DMPK Zagreb, Croatia, September 4-7, 2017
Институција/група
PharmacyTY - CONF AU - Popović-Nikolić, Marija AU - Popović, Gordana AU - Agbaba, Danica PY - 2017 UR - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4685 AB - Rupatadine is selective second-generation H1 antagonist, used in seasonal allergic rhinitis and chronic urticaria, and reported to be an antagonist to platelet-activating factor. Rupatadine contains three ionizable basic centers, two aromatic and one cyclic aliphatic amine. The pharmaceutical dosage forms for oral administration contain rupatadine fumarate as an active substance. A complex system of protolytic equilibria establishes in the solution of rupatadine fumarate which includes three basic centers of rupatadine and two acidic groups of fumaric acid. The data on the physicochemical properties of drugs determined in aqueous solution is not sufficient for the prediction of solubility and bioavailability in physiological conditions that are significantly more complex. For a better understanding of pharmacological behavior of ionizable drugs their physicochemical properties should be investigated under conditions more similar to physiological. As the biomembrane mimetic systems micellar solutions of surfactants can be used. The aim of this study was to investigate the effect of micellar solutions of differently charged surfactants sodium dodecyl sulfate (SDS), cetyltrimethylammonium bromide (CTAB) and 4-octylphenol polyethoxylate (TX-100), as biomembrane mimetic systems, on protolytic equilibria of rupatadine. The solutions (5×10-4 M) with and without of the 0.01 M surfactants were titrated with standard NaOH solution (0.0983 M) at a constant ionic strength (0.1 M NaCl) and temperature 25°C. Experimental data obtained by potentiometric titration were analyzed in the program Hyperquad. The pKa values of rupatadine (pKa1 = 3.45, pKa2 = 4.72, pKa3 = 6.75) were determined and the ionization was defined in aqueous media. The shift in protolytic equilibria was observed based on the pKa values of rupatadine determined in the presence of surfactants, anionic SDS (ΔpKa up to +1.44); cationic CTAB (ΔpKa up to -1.99) and nonionic TX-100 (ΔpKa up to -0.69). Different types of interactions between rupatadine and micelles were assumed. Rupatadine ionizable groups participate in electrostatic interactions with the ionic SDS and CTAB micelles and are involved in the interactions with a hydrophilic layer of nonionic TX-100 micelles. Observed shift in protolytic equilibria at biopharmaceutically significante pH values can be considered in the presence of biomolecules with various charge and polarity in physiological conditions. PB - International Association of Physical Chemists C3 - 6th IAPC Meeting Sixth World Conference on Physico-Chemical Methods in Drug Discovery & Third World Conference on ADMET and DMPK (Book of Abstracts) T1 - Protolytic equilibria of rupatadine in micellar solutions of differently charged surfactants SP - 43 EP - 43 UR - https://hdl.handle.net/21.15107/rcub_farfar_4685 ER -
@conference{ author = "Popović-Nikolić, Marija and Popović, Gordana and Agbaba, Danica", year = "2017", abstract = "Rupatadine is selective second-generation H1 antagonist, used in seasonal allergic rhinitis and chronic urticaria, and reported to be an antagonist to platelet-activating factor. Rupatadine contains three ionizable basic centers, two aromatic and one cyclic aliphatic amine. The pharmaceutical dosage forms for oral administration contain rupatadine fumarate as an active substance. A complex system of protolytic equilibria establishes in the solution of rupatadine fumarate which includes three basic centers of rupatadine and two acidic groups of fumaric acid. The data on the physicochemical properties of drugs determined in aqueous solution is not sufficient for the prediction of solubility and bioavailability in physiological conditions that are significantly more complex. For a better understanding of pharmacological behavior of ionizable drugs their physicochemical properties should be investigated under conditions more similar to physiological. As the biomembrane mimetic systems micellar solutions of surfactants can be used. The aim of this study was to investigate the effect of micellar solutions of differently charged surfactants sodium dodecyl sulfate (SDS), cetyltrimethylammonium bromide (CTAB) and 4-octylphenol polyethoxylate (TX-100), as biomembrane mimetic systems, on protolytic equilibria of rupatadine. The solutions (5×10-4 M) with and without of the 0.01 M surfactants were titrated with standard NaOH solution (0.0983 M) at a constant ionic strength (0.1 M NaCl) and temperature 25°C. Experimental data obtained by potentiometric titration were analyzed in the program Hyperquad. The pKa values of rupatadine (pKa1 = 3.45, pKa2 = 4.72, pKa3 = 6.75) were determined and the ionization was defined in aqueous media. The shift in protolytic equilibria was observed based on the pKa values of rupatadine determined in the presence of surfactants, anionic SDS (ΔpKa up to +1.44); cationic CTAB (ΔpKa up to -1.99) and nonionic TX-100 (ΔpKa up to -0.69). Different types of interactions between rupatadine and micelles were assumed. Rupatadine ionizable groups participate in electrostatic interactions with the ionic SDS and CTAB micelles and are involved in the interactions with a hydrophilic layer of nonionic TX-100 micelles. Observed shift in protolytic equilibria at biopharmaceutically significante pH values can be considered in the presence of biomolecules with various charge and polarity in physiological conditions.", publisher = "International Association of Physical Chemists", journal = "6th IAPC Meeting Sixth World Conference on Physico-Chemical Methods in Drug Discovery & Third World Conference on ADMET and DMPK (Book of Abstracts)", title = "Protolytic equilibria of rupatadine in micellar solutions of differently charged surfactants", pages = "43-43", url = "https://hdl.handle.net/21.15107/rcub_farfar_4685" }
Popović-Nikolić, M., Popović, G.,& Agbaba, D.. (2017). Protolytic equilibria of rupatadine in micellar solutions of differently charged surfactants. in 6th IAPC Meeting Sixth World Conference on Physico-Chemical Methods in Drug Discovery & Third World Conference on ADMET and DMPK (Book of Abstracts) International Association of Physical Chemists., 43-43. https://hdl.handle.net/21.15107/rcub_farfar_4685
Popović-Nikolić M, Popović G, Agbaba D. Protolytic equilibria of rupatadine in micellar solutions of differently charged surfactants. in 6th IAPC Meeting Sixth World Conference on Physico-Chemical Methods in Drug Discovery & Third World Conference on ADMET and DMPK (Book of Abstracts). 2017;:43-43. https://hdl.handle.net/21.15107/rcub_farfar_4685 .
Popović-Nikolić, Marija, Popović, Gordana, Agbaba, Danica, "Protolytic equilibria of rupatadine in micellar solutions of differently charged surfactants" in 6th IAPC Meeting Sixth World Conference on Physico-Chemical Methods in Drug Discovery & Third World Conference on ADMET and DMPK (Book of Abstracts) (2017):43-43, https://hdl.handle.net/21.15107/rcub_farfar_4685 .